Boeing To Rally More Than 25%? Here Are 10 Top Analyst Forecasts For Tuesday

Benzinga ·  11/28/2023 21:09

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. UBS cut ChargePoint Holdings, Inc. (NYSE:CHPT) price target from $9 to $2.25. UBS analyst Robert Jamieson downgraded the stock from Buy to Neutral. ChargePoint shares fell 0.5% to $1.98 in pre-market trading. See how other analysts view this stock.RBC Capital increased the price target for Xenon Pharmaceuticals Inc. (NASDAQ:XENE) from $51 to $56. RBC Capital analyst Brian Abrahams maintained an Outperform rating. Xenon Pharmaceuticals shares jumped 17.8% to close at $34.12 on Monday. See

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment